Detalles de la búsqueda
1.
High-yield identification of pathogenic NF1 variants by skin fibroblast transcriptome screening after apparently normal diagnostic DNA testing.
Hum Mutat
; 43(12): 2130-2140, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36251260
2.
Diagnostic value of 18F-FDG PET-CT in detecting malignant peripheral nerve sheath tumors among adult and pediatric neurofibromatosis type 1 patients.
J Neurooncol
; 156(3): 559-567, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35025020
3.
Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study.
Lancet Oncol
; 22(6): 813-823, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34000245
4.
Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations.
Acta Neuropathol
; 141(6): 945-957, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33740099
5.
Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Lancet Oncol
; 21(6): e305-e316, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32502457
6.
Lomustine and Bevacizumab in Progressive Glioblastoma.
N Engl J Med
; 377(20): 1954-1963, 2017 11 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-29141164
7.
Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study.
Lancet
; 390(10103): 1645-1653, 2017 Oct 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28801186
8.
Worries and needs of adults and parents of adults with neurofibromatosis type 1.
Am J Med Genet A
; 176(5): 1150-1160, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29681082
9.
Treatment of large low-grade oligodendroglial tumors with upfront procarbazine, lomustine, and vincristine chemotherapy with long follow-up: a retrospective cohort study with growth kinetics.
J Neurooncol
; 121(2): 365-72, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25344884
10.
Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial.
Lancet Oncol
; 15(9): 943-53, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25035291
11.
Quality of life in individuals with neurofibromatosis type 1 associated cutaneous neurofibromas: validation of the Dutch cNF-Skindex.
J Patient Rep Outcomes
; 8(1): 52, 2024 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38811427
12.
The PlexiQoL, a patient-reported outcome measure on quality of life in neurofibromatosis type 1-associated plexiform neurofibroma: translation, cultural adaptation and validation into the Dutch language for the Netherlands.
J Patient Rep Outcomes
; 8(1): 33, 2024 Mar 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38499890
13.
[Symptomatic tumors in neurofibromatosis type 1: a diagnostic challenge]. / Symptomatische tumoren bij neurofibromatose type 1.
Ned Tijdschr Geneeskd
; 1672023 11 22.
Artículo
en Neerlandesa
| MEDLINE | ID: mdl-37994710
14.
Isolated cerebellar metastasis from urothelial carcinoma: A case report of a rare phenomenon.
Brain Spine
; 3: 102716, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38105804
15.
Practice variation in re-resection for recurrent glioblastoma: A nationwide survey among Dutch neuro-oncology specialists.
Neurooncol Pract
; 10(4): 360-369, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37457228
16.
Early and late contrast enhancing lesions after photon radiotherapy for IDH mutated grade 2 diffuse glioma.
Radiother Oncol
; 184: 109674, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37084885
17.
Endocrine and non-endocrine causes of fatigue in adults with Neurofibromatosis type 1.
Front Endocrinol (Lausanne)
; 14: 1119159, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38560379
18.
Health-related quality-of-life results from the randomised phase II TAVAREC trial on temozolomide with or without bevacizumab in 1p/19q intact first-recurrence World Health Organization grade 2 and 3 glioma (European Organization for Research and Treatment of Cancer 26091).
Eur J Cancer
; 190: 112946, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37453240
19.
Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study.
J Neurooncol
; 108(1): 195-200, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22396071
20.
Efficacy of opioid rotation to continuous parenteral hydromorphone in advanced cancer patients failing on other opioids.
Support Care Cancer
; 20(8): 1639-47, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21861200